icon-folder.gif   Conference Reports for NATAP  
 
  62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9 Back grey_arrow_rt.gif
 
 
 
MK-5172, a Second Generation HCV NS3/4A Protease Inhibitor is Active Against Common Resistance Associated Variants (RAVs) and Exhibits Cross-Genotype Activity
 
 
  Reported by Jules Levin AASLD 2011 San Francisco Nov 6-9
 
Donald Graham, Adriana Acosta, Zhuyan Guo, John A. Howe, Robert Ogert, Michael Miller, Daria Hazuda, David Olsen, Steven Ludmerer, Julie M Strizki and Richard J.O. Barnard Merck and Co, Whitehouse Station, NJ, USA

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif